Greenwich lifesciences inc

WebSep 29, 2024 · STAFFORD, Texas-- ( BUSINESS WIRE )--Greenwich LifeSciences, Inc. (the “Company”), a clinical-stage biopharmaceutical company focused on the … WebBy proceeding to use this website, you consent to our use of cookies as described in our Privacy Policy.. Close

Jaye Thompson Purchases 1,000 Shares of Greenwich LifeSciences, Inc ...

WebDec 1, 2024 · Greenwich LifeSciences Provides Year End Update Dec 1, 2024 6:00am EST Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024 Featured Events View All Events There are no events to show at this time. Sign up here to receive notices about upcoming events. WebApr 6, 2024 · Greenwich Lifesciences Inc ( GLSI) is around the top of the Biotechnology industry according to InvestorsObserver. GLSI received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. the prayers of john calvin https://glassbluemoon.com

Does Greenwich Lifesciences Inc (GLSI) Have What it Takes to be …

WebApr 10, 2024 · Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following … WebApr 14, 2024 · Greenwich LifeSciences has a 52-week low of $6.82 and a 52-week high of $21.50. The stock’s fifty day simple moving average is $14.92 and its 200-day simple moving average is $13.48. The... WebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, April 11th.The shares were bought at an average price of $11.87 per share, for a total transaction of $11,870.00. Following the completion of the transaction, the vice president now owns … sift- sans investigative forensic toolkit

GREENWICH LIFESCIENCES, INC. : Other Events (form 8-K)

Category:Contact Greenwich LifeSciences, Inc. (GLSI) GP2

Tags:Greenwich lifesciences inc

Greenwich lifesciences inc

Corporate Governance Greenwich LifeSciences, Inc. (GLSI) GP2

WebCancer and Immunotherapy Overview Greenwich LifeSciences, Inc. (GLSI) GP2 Cancer and Immunotherapy A Background on Immunotherapy’s Potential in Defeating Cancer TECHNOLOGY OVERVIEW GP2 PRODUCT IMMUNOTHERAPY BACKGROUND Cancer Immunotherapies are a New Method of Cancer Treatment

Greenwich lifesciences inc

Did you know?

WebApr 10, 2024 · Currently, the analyst consensus on Greenwich LifeSciences is a Moderate Buy with an average price target of $38.00. See Insiders’ Hot Stocks on TipRanks >> … WebDec 1, 2024 · STAFFORD, Texas, December 01, 2024 -- ( BUSINESS WIRE )--Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of...

WebLegal Name Greenwich LifeSciences, Inc. Stock Symbol NASDAQ:GLSI ; Company Type For Profit; Contact Email [email protected]; Phone Number (832) 819-3232; WebSnehal S. Patel Chief Executive Officer. Over 30 years of experience in executive management, corporate development, operations, and investment banking in the …

WebApr 6, 2024 · A high-level overview of Greenwich LifeSciences, Inc. (GLSI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebGet the latest Greenwich Lifesciences Inc (GLSI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

WebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 1-year low of $6.82 and a 1-year high of $21.50. The stock has a market cap of $153.81 million, a PE ratio of -21.00 and a beta of …

WebOct 4, 2024 · Business Wire. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast … sift science shopifyWebMar 8, 2024 · Shares of Greenwich LifeSciences ( GLSI 0.80%) were skyrocketing 48.8% higher as of 3:19 p.m. EST on Monday. The huge jump came after the company announced the hiring of Jaye Thompson as vice... sift science pricingWebApr 14, 2024 · On Friday, March 10th, Snehal Patel bought 1,000 shares of Greenwich LifeSciences stock. The stock was bought at an average cost of $12.12 per share, with a total value of $12,120.00. the prayers of the faithful availeth muchWebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 1-year low of $6.82 and a 1-year high of $21.50. The stock has a market cap of $153.81 million, a PE ratio of -21.00 and a beta of 0.93. the prayers of the faithfulWebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 12-month low of $6.82 and a 12-month high of $21.50. The firm’s 50-day moving average price is $14.92 and its two-hundred day moving average price is $13.48. the prayers of the righteous are powerfulWebApr 11, 2024 · NASDAQ:GLSI opened at $12.65 on Monday. Greenwich LifeSciences has a 52 week low of $6.82 and a 52 week high of $21.50. The stock’s fifty day moving average is $15.24 and its two-hundred day ... the prayers of the people anglicanWebApr 10, 2024 · A rating of 81 puts Greenwich Lifesciences Inc ( GLSI) near the top of the Healthcare sector according to InvestorsObserver . Greenwich Lifesciences Inc's score … the prayers of many